SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference

SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference CAMBRIDGE, Mass. – September 30, 2019 – SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, President and Chief Executive Officer, will present [...]

By |2019-09-30T10:32:50-04:00September 30th, 2019|Press Releases|0 Comments

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors Published: Sep 05, 2019 CAMBRIDGE, Mass., Sept. 5, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of Fred Driscoll to its Board of Directors. Mr. [...]

By |2019-09-05T11:15:42-04:00September 5th, 2019|Press Releases|0 Comments

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer CAMBRIDGE, Mass. – June 25, 2019 – SmartPharm Therapeutics, a pre-clinical stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, has been appointed Chief Executive Officer. Dr. [...]

By |2019-06-28T12:49:33-04:00June 25th, 2018|Press Releases|Comments Off on SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer